ActiveRADAR, now a part of Surescripts, LLC.

We bridge the gap between lower drug costs and better healthcare outcomes by offering employers and employees effective alternatives.

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

ActiveRADAR P&T Committee approves Biosimilar Policy for Value-based Reimbursement program; Reference Pricing now applied to 79 drug categories

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

Today Norrie Thomas, ActiveRADARs' own Chief Pharmacist, is giving a presentation at AMCP Nexus 2020 on Practical Applications to Close Gender and Diversity Gaps in Health Care Leadership. Make sure to check it out!
https://t.co/4BfOC00vzO

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

Prescription drugs, represent the third-largest and fastest-growing cost center in healthcare. Reference pricing programs can reduce costs by establishing therapeutic equivalent benchmarks to encourage members to select least expensive alternatives.
https://t.co/SvUGnrcsEo

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

In the US, prices for therapeutically similar drugs vary widely. Reference pricing can help reduce variability while providing the best & clinically appropriate care. Reference pricing is associated with significant changes in drug selection and spending https://t.co/k2PYBZ5KKW

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

As this article articulates high and rising health care prices play a major role in the persistent increases in health care spending. Reference pricing can help lower costs!
https://t.co/H7tQIpyz1s

#referencepricing #healthcare

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

COVID-19 could fuel rapid progress to value-based care. Reference Pricing is a value-based care strategy-- limiting payor cost share to a single reimbursement rate for all drugs in a category deemed to be therapeutically equivalent alternatives. https://t.co/xw9BIunmvs

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

With the conclusion of its June P&T Committee meeting, ActiveRADAR completed its annual review of 72 drug categories that Reference Pricing may be applied. This is foundational to the process of developing ActiveRADAR’s compendia of client-tailored reference pricing oportunities.

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

Like SureScript's Real Time Benefit service, AR provides dispensing pharmacies point of sale information on lower cost, therapeutic alternatives, but AR takes the extra step of resetting plan sponsor and member cost shares creating immediate savings https://t.co/U1tDu9Ix6P

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

We wanted to introduce you to more of our team. Dr. Norrie Thomas is on our board of directors and has been a trail blazing leader in the world of managed care and pharmacy. ActiveRADAR is lucky to have her on our team!
https://t.co/W4VHDQ8eEA

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

In case you missed it, JAMA ran a study on reference pricing! Read about how our #referencepricing solution can save employers and their employees money on #prescriptions. https://t.co/9Ww0fXkGpG

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

COVID19 is causing individuals to lose their jobs/health insurance Medicaid enrollment continues to rise.Drug Channels reviews how this is going to affect pharmacies and PBMs.Using #referencepricing to help control #drugprices is more important than ever!
https://t.co/AFgI6bEvzP

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

We are excited to announce that @MahonRowan PharmD/MPH/MHI has joined our team. Rowan has a unique background in research, data analytics, and pharmacy. She will be a great asset to ActiveRADAR.

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

As this article clearly demonstrates drug pricing is complicated, from list price, net price, WAC, etc... it can get confusing very quickly. ActiveRADAR knows one thing that isn’t complicated or confusing, though: reference drug pricing helps lower costs.
https://t.co/9iF8VWjzds

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

ActiveRADAR is a leader in reference based pricing (RBP). RBP can help reduce and control medication costs, which is becoming even more important during the COVID19 pandemic. This article is a great introduction into that concept. https://t.co/1HOau8L2fU

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

Thank you AMCP!

[AMCP @amcporg]

Cheers go out to @RichardZabinski for winning the Distinguished Service Award, an honor recognizing an AMCP member who has made exceptional & sustained contributions to AMCP over at least a 5-year period! Get to know Mr. Zabinski: https://t.co/EjdQmRaDJn

#AMCPAwards #IAmAMCP

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

Congratulations to Richard Zabinski, our vice president of product development and clinical operations. He has been awarded the #AMCP Distinguished Service Award for 2020. We are lucky to have him on our team!!

https://t.co/67jNBjrDlE

[Employee Benefit News @EBNbenefitnews]

How reference based pricing can recession proof your benefits https://t.co/EjWVtIfYgs

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

ActiveRADAR is addressing out-of-control #prescription costs head on. Learn about the power #referencepricing has to combat rising #drug costs.
https://t.co/dvtJyxKd3e

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

#Drugpricing legislation is struggling to find momentum amidst coronavirus news and policy issues. Learn more from @politico. https://t.co/B58Hi8RycB

[ActiveRADAR, now a part of Surescripts, LLC. @ActiveRADAR]

In the wake of last night's #DemDebate2020, some clear distinctions were drawn between the two contenders' #drugpricing policies. Learn more from @FierceHealth. https://t.co/oqCCsfeBiK